These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15341696)

  • 1. Comparison of oral versus intravenous phytonadione in patients with excessive anticoagulation.
    Key N
    Curr Hematol Rep; 2004 Sep; 3(5):315-6. PubMed ID: 15341696
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of intravenous phytonadione (vitamin K1) in patients on long-term oral anticoagulant therapy.
    Shields RC; McBane RD; Kuiper JD; Li H; Heit JA
    Mayo Clin Proc; 2001 Mar; 76(3):260-6. PubMed ID: 11243272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study.
    Lubetsky A; Yonath H; Olchovsky D; Loebstein R; Halkin H; Ezra D
    Arch Intern Med; 2003 Nov; 163(20):2469-73. PubMed ID: 14609783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis.
    Dezee KJ; Shimeall WT; Douglas KM; Shumway NM; O'malley PG
    Arch Intern Med; 2006 Feb; 166(4):391-7. PubMed ID: 16505257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an International Normalised Ratio above 10.0.
    Denas G; Cucchini U; Iliceto S; Pengo V
    Thromb Haemost; 2009 Feb; 101(2):410-1. PubMed ID: 19190831
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticoagulation interruptus: not without risk.
    Ezekowitz MD
    Circulation; 2004 Sep; 110(12):1518-9. PubMed ID: 15381656
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of anticoagulation in patients with prosthetic heart valves undergoing oral and maxillofacial operations.
    Webster K; Wilde J
    Br J Oral Maxillofac Surg; 2000 Apr; 38(2):124-6. PubMed ID: 10864707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and effectiveness of low dose oral vitamin K1 administration in asymptomatic out-patients on warfarin or acenocoumarol with excessive anticoagulation.
    Poli D; Antonucci E; Lombardi A; Gensini GF; Abbate R; Prisco D
    Haematologica; 2003 Feb; 88(2):237-8. PubMed ID: 12604423
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral anticoagulant therapy. Fundamentals, clinical practice and recommendations.
    Lemos Silva R; Carvalho de Sousa J; Calisto C; Braz Nogueira JM; Ravara L
    Rev Port Cardiol; 2007; 26(7-8):769-88. PubMed ID: 17939586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term oral coagulation. Self monitoring prevents complication].
    MMW Fortschr Med; 2003 May; 145(19):53. PubMed ID: 12813982
    [No Abstract]   [Full Text] [Related]  

  • 11. Once atrial fibrillation, always oral anticoagulation?
    Verheugt FW
    Thromb Res; 2007; 119(3):275-6. PubMed ID: 16426666
    [No Abstract]   [Full Text] [Related]  

  • 12. Warfarin therapy for elderly persons with atrial fibrillation.
    Wieman HM
    Am Fam Physician; 1998 Jul; 58(1):49, 52. PubMed ID: 9672430
    [No Abstract]   [Full Text] [Related]  

  • 13. Periprocedural management of anticoagulation in patients on extended warfarin therapy.
    Jafri SM; Mehta TP
    Semin Thromb Hemost; 2004 Dec; 30(6):657-64. PubMed ID: 15630672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
    Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of oral anticoagulants (warfarin) in older people. AGS Clinical Practices Committee. American Geriatric Society.
    J Am Geriatr Soc; 2000 Feb; 48(2):224-7. PubMed ID: 10682955
    [No Abstract]   [Full Text] [Related]  

  • 17. Vitamin K1 antagonisation is not safe in high thromboembolic risk patients with over-anticoagulation.
    Champion S; Cleophax C; Voicu S; Sirol M; Deye N; J Baud F
    Therapie; 2014; 69(3):251-2. PubMed ID: 24901290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral anticoagulant therapy for patients with atrial fibrillation--an update.
    Hylek EM
    Thromb Res; 2008; 123 Suppl 1():S46-9. PubMed ID: 18809205
    [No Abstract]   [Full Text] [Related]  

  • 19. Guidelines on oral anticoagulation (warfarin): third edition--2005 update.
    Baglin TP; Keeling DM; Watson HG;
    Br J Haematol; 2006 Feb; 132(3):277-85. PubMed ID: 16409292
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current issues in the initial phase of warfarin therapy].
    Squizzato A; Steidl L; Ageno W
    Recenti Prog Med; 2005 Dec; 96(12):612-5. PubMed ID: 16496748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.